Literature DB >> 16210841

Patent ductus arteriosus and respiratory outcome in premature infants.

Eduardo Bancalari1, Nelson Claure, Alvaro Gonzalez.   

Abstract

A persistent ductus arteriosus is a common event in preterm infants. The systemic-to-pulmonary shunting that occurs as the pulmonary vascular resistance decreases after birth can have significant cardiovascular and respiratory consequences. Acute pulmonary effects include pulmonary edema and hemorrhage, worsened lung mechanics and deterioration in gas exchange with hypoxemia and hypercapnia. The increased pulmonary blood flow can also produce damage to the capillary endothelium and trigger an inflammatory cascade. This, plus the need for longer and more aggressive mechanical ventilation, can explain the association between patent ductus arteriosus and an increased risk for bronchopulmonary dysplasia in extremely premature infants. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210841     DOI: 10.1159/000087582

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  21 in total

1.  Improved closure of patent ductus arteriosus with high doses of ibuprofen.

Authors:  Udo Meißner; Raktima Chakrabarty; Hans-Georg Topf; Wolfgang Rascher; Michael Schroth
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

2.  Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia.

Authors:  Jen-Ruey Tang; S Ananth Karumanchi; Gregory Seedorf; Neil Markham; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-14       Impact factor: 5.464

Review 3.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

4.  Indomethacin vs ibuprofen: comparison of efficacy in the setting of conservative therapeutic approach.

Authors:  Andra Malikiwi; Charlene Roufaeil; Kenneth Tan; Arvind Sehgal
Journal:  Eur J Pediatr       Date:  2014-10-26       Impact factor: 3.183

Review 5.  Bronchopulmonary dysplasia: Pathogenesis and treatment.

Authors:  Asfia Banu Pasha; Xiao-Qing Chen; Guo-Ping Zhou
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

6.  Genetic contribution to patent ductus arteriosus in the premature newborn.

Authors:  Vineet Bhandari; Gongfu Zhou; Matthew J Bizzarro; Catalin Buhimschi; Naveed Hussain; Jeffrey R Gruen; Heping Zhang
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

Review 7.  Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration.

Authors:  Sindhu Sivanandan; Ramesh Agarwal
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

8.  Platelets contribute to postnatal occlusion of the ductus arteriosus.

Authors:  Katrin Echtler; Konstantin Stark; Michael Lorenz; Sandra Kerstan; Axel Walch; Luise Jennen; Martina Rudelius; Stefan Seidl; Elisabeth Kremmer; Nikla R Emambokus; Marie-Luise von Bruehl; Jon Frampton; Berend Isermann; Orsolya Genzel-Boroviczény; Christian Schreiber; Julinda Mehilli; Adnan Kastrati; Markus Schwaiger; Ramesh A Shivdasani; Steffen Massberg
Journal:  Nat Med       Date:  2009-12-06       Impact factor: 53.440

9.  Hybrid management of a large atrial septal defect and a patent ductus arteriosus in an infant with chronic lung disease.

Authors:  Simone F Pedra; Marcelo Jatene; Carlos Ac Pedra
Journal:  Ann Pediatr Cardiol       Date:  2010-01

10.  Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants.

Authors:  J R Benjamin; P B Smith; C M Cotten; J Jaggers; R F Goldstein; W F Malcolm
Journal:  J Perinatol       Date:  2009-09-17       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.